355 related articles for article (PubMed ID: 25019052)
1. Circulating microRNAs as biomarkers for inflammatory diseases.
Mi S; Zhang J; Zhang W; Huang RS
Microrna; 2013; 2(1):63-71. PubMed ID: 25019052
[TBL] [Abstract][Full Text] [Related]
2. Integration of genetics and miRNA-target gene network identified disease biology implicated in tissue specificity.
Sakaue S; Hirata J; Maeda Y; Kawakami E; Nii T; Kishikawa T; Ishigaki K; Terao C; Suzuki K; Akiyama M; Suita N; Masuda T; Ogawa K; Yamamoto K; Saeki Y; Matsushita M; Yoshimura M; Matsuoka H; Ikari K; Taniguchi A; Yamanaka H; Kawaji H; Lassmann T; Itoh M; Yoshitomi H; Ito H; Ohmura K; R Forrest AR; Hayashizaki Y; Carninci P; Kumanogoh A; Kamatani Y; de Hoon M; Yamamoto K; Okada Y
Nucleic Acids Res; 2018 Dec; 46(22):11898-11909. PubMed ID: 30407537
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs: Emerging Regulators of Immune-Mediated Diseases.
Tomankova T; Petrek M; Gallo J; Kriegova E
Scand J Immunol; 2012 Feb; 75(2):129-41. PubMed ID: 21988491
[TBL] [Abstract][Full Text] [Related]
4. Circulating microRNAs as biomarkers in patients with allergic rhinitis and asthma.
Panganiban RP; Wang Y; Howrylak J; Chinchilli VM; Craig TJ; August A; Ishmael FT
J Allergy Clin Immunol; 2016 May; 137(5):1423-32. PubMed ID: 27025347
[TBL] [Abstract][Full Text] [Related]
5. Methodological challenges in utilizing miRNAs as circulating biomarkers.
Moldovan L; Batte KE; Trgovcich J; Wisler J; Marsh CB; Piper M
J Cell Mol Med; 2014 Mar; 18(3):371-90. PubMed ID: 24533657
[TBL] [Abstract][Full Text] [Related]
6. The emerging role of circulating microRNAs as biomarkers in autoimmune diseases.
Zeng L; Cui J; Wu H; Lu Q
Autoimmunity; 2014 Nov; 47(7):419-29. PubMed ID: 24953646
[TBL] [Abstract][Full Text] [Related]
7. Extracellular microRNA: a new source of biomarkers.
Etheridge A; Lee I; Hood L; Galas D; Wang K
Mutat Res; 2011 Dec; 717(1-2):85-90. PubMed ID: 21402084
[TBL] [Abstract][Full Text] [Related]
8. Circulating microRNAs: a novel class of potential biomarkers for diagnosing and prognosing central nervous system diseases.
Jin XF; Wu N; Wang L; Li J
Cell Mol Neurobiol; 2013 Jul; 33(5):601-13. PubMed ID: 23633081
[TBL] [Abstract][Full Text] [Related]
9. miRNAs and rheumatoid arthritis - promising novel biomarkers.
Duroux-Richard I; Jorgensen C; Apparailly F
Swiss Med Wkly; 2011; 141():w13175. PubMed ID: 21416408
[TBL] [Abstract][Full Text] [Related]
10. Profiling microRNAs in individuals at risk of progression to rheumatoid arthritis.
Ouboussad L; Hunt L; Hensor EMA; Nam JL; Barnes NA; Emery P; McDermott MF; Buch MH
Arthritis Res Ther; 2017 Dec; 19(1):288. PubMed ID: 29273071
[TBL] [Abstract][Full Text] [Related]
11. New advances of microRNAs in the pathogenesis of rheumatoid arthritis, with a focus on the crosstalk between DNA methylation and the microRNA machinery.
Miao CG; Yang YY; He X; Xu T; Huang C; Huang Y; Zhang L; Lv XW; Jin Y; Li J
Cell Signal; 2013 May; 25(5):1118-25. PubMed ID: 23385088
[TBL] [Abstract][Full Text] [Related]
12. Utility of circulating microRNAs as clinical biomarkers for cardiovascular diseases.
Kondkar AA; Abu-Amero KK
Biomed Res Int; 2015; 2015():821823. PubMed ID: 25710029
[TBL] [Abstract][Full Text] [Related]
13. Circulating microRNA expression profiles associated with systemic lupus erythematosus.
Carlsen AL; Schetter AJ; Nielsen CT; Lood C; Knudsen S; Voss A; Harris CC; Hellmark T; Segelmark M; Jacobsen S; Bengtsson AA; Heegaard NH
Arthritis Rheum; 2013 May; 65(5):1324-34. PubMed ID: 23401079
[TBL] [Abstract][Full Text] [Related]
14. Circulating microRNAs in hematological diseases: principles, challenges, and perspectives.
Grasedieck S; Sorrentino A; Langer C; Buske C; Döhner H; Mertens D; Kuchenbauer F
Blood; 2013 Jun; 121(25):4977-84. PubMed ID: 23550041
[TBL] [Abstract][Full Text] [Related]
15. Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review).
Allegra A; Alonci A; Campo S; Penna G; Petrungaro A; Gerace D; Musolino C
Int J Oncol; 2012 Dec; 41(6):1897-912. PubMed ID: 23026890
[TBL] [Abstract][Full Text] [Related]
16. Circulating miRNAs as potential biomarkers of therapy effectiveness in rheumatoid arthritis patients treated with anti-TNFα.
Castro-Villegas C; Pérez-Sánchez C; Escudero A; Filipescu I; Verdu M; Ruiz-Limón P; Aguirre MA; Jiménez-Gomez Y; Font P; Rodriguez-Ariza A; Peinado JR; Collantes-Estévez E; González-Conejero R; Martinez C; Barbarroja N; López-Pedrera C
Arthritis Res Ther; 2015 Mar; 17(1):49. PubMed ID: 25860297
[TBL] [Abstract][Full Text] [Related]
17. Micro-RNAs in inflammatory diseases and as a link between inflammation and cancer.
Ranjha R; Paul J
Inflamm Res; 2013 Apr; 62(4):343-55. PubMed ID: 23417288
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of microRNAs in autoimmune diseases: Pathogenesis, biomarkers and potential therapeutic targets.
Long H; Wang X; Chen Y; Wang L; Zhao M; Lu Q
Cancer Lett; 2018 Aug; 428():90-103. PubMed ID: 29680223
[TBL] [Abstract][Full Text] [Related]
19. Circulating MicroRNAs: Potential and Emerging Biomarkers for Diagnosis of Cardiovascular and Cerebrovascular Diseases.
Li M; Zhang J
Biomed Res Int; 2015; 2015():730535. PubMed ID: 26180810
[TBL] [Abstract][Full Text] [Related]
20. Circulating MicroRNAs as Potential Biomarkers of Exercise Response.
Polakovičová M; Musil P; Laczo E; Hamar D; Kyselovič J
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27782053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
